|
MCID: TMR002
|
Tumoral Calcinosis, Hyperphosphatemic malady |
|
Sources: 33OMIM, 22MalaCards See all sources Export this MalaCard |
MalaCards: Tumoral Calcinosis, Hyperphosphatemic, also known as tumoral calcinosis, is related to calcinosis and hyperphosphatemic familial tumoral calcinosis. An important gene associated with Tumoral Calcinosis, Hyperphosphatemic is FGF23 (fibroblast growth factor 23), and among its related pathways is Signaling by EGFR. Related mouse phenotypes are reproductive system and limbs/digits/tail.
OMIM: 211900 |
|
Sources: 33OMIM, 32Novoseek , 43UMLS See all sources |
|
Sources: 33OMIM See all sources |
Clinical features from OMIM: 211900
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for tumoral calcinosis, hyperphosphatemic Drug clinical trials:Search ClinicalTrials for tumoral calcinosis, hyperphosphatemic Search NIH Clinical Center for tumoral calcinosis, hyperphosphatemic Search CenterWatch for tumoral calcinosis, hyperphosphatemic |
|
|
|
|
|
Sources: 25MGI See all sources |
MGI Mouse Phenotypes related to tumoral calcinosis, hyperphosphatemic:25
|
|
|
|
Sources: 1BioGPS See all sources |
![]() |
|
Sources: 38Reactome See all sources |
Pathways related to tumoral calcinosis, hyperphosphatemic according to GeneDecks:
|
|
|
|
Sources: 12Gene Ontology See all sources |
Biological processes related to tumoral calcinosis, hyperphosphatemic according to GeneDecks:
|
